Eaton Vance Management Exact Sciences Corp Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Exact Sciences Corp stock. As of the latest transaction made, Eaton Vance Management holds 222,122 shares of EXAS stock, worth $10.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

222,122

Previous 221,168 0.43%

Holding current value

$10.4 Million

Previous $8.71 Million 17.16%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $30,499 - $47,098	954 Added 0.43%	222,122 $7.22 Million
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $6.44 Million - $13.8 Million	-180,975 Reduced 45.0%	221,168 $8.71 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $2.21 Million - $3.18 Million	38,468 Added 10.58%	402,143 $28.1 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $573,402 - $796,278	7,909 Added 2.22%	363,675 $28.2 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $263,410 - $362,101	2,919 Added 0.83%	355,766 $33.8 Million
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $44,956 - $66,849	-480 Reduced 0.14%	352,847 $43.9 Million
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $7.08 Million - $9.41 Million	60,727 Added 20.75%	353,327 $46.6 Million
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $4.98 Million - $7.11 Million	50,006 Added 20.61%	292,600 $38.8 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $11.8 Million - $16.5 Million	-161,392 Reduced 39.95%	242,594 $24.7 Million
Q2 2020 Nov 20, 2020	BUY	$55.75 - $92.75 $8,251 - $13,727	148 Added 0.04%	403,986 $35.1 Million
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $23,972 - $39,882	-430 Reduced 0.11%	403,838 $35.1 Million
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $49,156 - $135,458	1,297 Added 0.32%	404,268 $23.5 Million
Q4 2019 Feb 11, 2020	BUY	$77.66 - $99.74 $12.5 Million - $16.1 Million	161,090 Added 66.6%	402,971 $37.3 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $27,111 - $36,747	300 Added 0.12%	241,881 $21.9 Million
Q2 2019 Nov 21, 2019	SELL	$89.51 - $118.04 $29,806 - $39,307	-333 Reduced 0.14%	241,581 $28.5 Million
Q2 2019 Aug 16, 2019	SELL	$89.51 - $118.04 $24 Million - $31.6 Million	-267,788 Reduced 52.54%	241,914 $28.5 Million
Q1 2019 May 14, 2019	BUY	$61.98 - $96.5 $3.78 Million - $5.89 Million	61,042 Added 13.61%	509,702 $44.2 Million
Q4 2018 Feb 07, 2019	BUY	$56.04 - $82.66 $14.4 Million - $21.3 Million	257,395 Added 134.58%	448,660 $28.3 Million
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $9.24 Million - $15.4 Million	191,265 New	191,265 $15.1 Million

Others Institutions Holding EXAS

# of Institutions

642

Shares Held

156M

Call Options Held

1.64M

Put Options Held

1.5M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Exact Sciences Corp Transaction History